Neuroscience
Agonist
100%
Nicotinic Acetylcholine Receptor
100%
Positive Allosteric Modulator
100%
Receptor Upregulation
18%
In Vivo
18%
Parasympathomimetic Drug
18%
Iodine-125
9%
Receptor
9%
Receptor down Regulation
9%
Autoradiograph
9%
Medicine and Dentistry
Upregulation
100%
Allosteric Modulator
100%
Nicotinic Receptor
100%
Receptor Upregulation
18%
Nicotinic Acetylcholine Receptor Agonist
18%
Autoradiograph
9%
Receptor
9%
Iodine 125
9%
Desensitization
9%
Receptor down Regulation
9%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Upregulation
100%
Nicotinic Acetylcholine Receptor
100%
Receptor Agonists
20%
Receptor Upregulation
20%
Iodine-125
10%
Bungarotoxin
10%
Receptor down Regulation
10%
Keyphrases
Positive Allosteric Modulator
100%
Nicotinic Acetylcholine Receptor (nAChR)
100%
Nicotine
36%
Receptor Downregulation
18%
125I
9%
Clinical Development
9%
Differential Sensitivity
9%
α-bungarotoxin
9%
Cognitive Effects
9%
Desensitization
9%
Long-term Treatment
9%
Autoradiography
9%
Protein Level
9%
Stably Expressing
9%
Receptor Desensitization
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nicotinic Receptor
100%
Positive Allosteric Modulator
100%
Receptor
27%
Desensitization
18%
Nicotinic Acetylcholine Receptor Agonist
18%
Iodine-125
9%
Autoradiography
9%